MentalHealthDaily

Alpha-Synuclein SAA Predicts Parkinson’s Levodopa Response Durability

by GLOOM

Photoreal illustration of CSF biomarker testing alongside dopaminergic neuron pathways, representing PD biomarker stratification.

A 2026 PPMI analysis found that Parkinson’s patients with positive CSF α-synuclein seed amplification assay results kept gaining levodopa benefit over follow-up, while SAA-negative patients showed faster ON-medication motor progression than SAA-positive patients: 0.87 vs. 3.47 MDS-UPDRS Part III points/year in 183 matched SAA-positive and 40 SAA-negative patients.1 Research Highlights ON-state progression split sharply: SAA-positive …

Leaded Gasoline and ALS: Australia’s MND Surge Tracks Lead

by GLOOM

Photoreal illustration linking historical leaded-petrol exposure with motor neurone disease, with imagery of a vintage gas pump and motor neuron motifs.

A 2026 Australian ecological model found that 20-year-lagged cumulative population blood-lead burden was nonlinearly tied to motor neuron disease mortality (lead spline p = 0.00024), while national insecticide use did not independently explain the curve after adjustment (p = 0.39).1 That is a real lead signal, but it is still population-level evidence, not proof that …

Alzheimer’s RVI-AD MRI Score Predicted Dementia Conversion With 0.70 AUC

by GLOOM

A 2026 Molecular Psychiatry study found that RVI-AD, a structural-MRI score measuring how closely a person’s brain anatomy matches an Alzheimer’s disease pattern, predicted mild-cognitive-impairment conversion to dementia most strongly over the next 3 years: OR 2.16, 95% CI 1.81-2.57, p < 2e-16, AUC 0.70.1 Research Highlights Short-term conversion signal: in 965 ADNI participants with …

Lecanemab Clears Amyloid via Microglia and Fc Receptors

by GLOOM

Photoreal illustration of microglia clustering around an amyloid plaque, conveying immune-mediated clearance mechanism.

A 2026 Nature Neuroscience study found that lecanemab cleared amyloid in a humanized-microglia Alzheimer’s disease model only when microglia and the antibody’s intact Fc fragment were both present: X-34 plaque area differed across IgG1, lecanemab, and Fc-silenced LALA-PG groups (P = 0.0003), 82E1 plaque area differed across groups (P < 0.0001), and microglia-deficient mice showed …

Total-Body Tau PET Links Brain-Organ Coupling to Alzheimer’s Cognition

by GLOOM

Photoreal illustration of brain with cardiac and respiratory rhythm overlays, conveying brain-body coupling and AD pathology.

A 2026 total-body tau-PET study of 28 people with Alzheimer’s disease and 23 biomarker-negative controls found stronger brain-organ network connectivity in Alzheimer’s disease than in biomarker-negative controls: 35 altered connections, including 21 brain-body edges, plus AD-only links between brain-organ coupling, cortical tau burden, MRI-derived glymphatic markers, and cognition.1 The result is best read as a …

Sleep Memory Cues Do Not Boost Parkinson’s Motor Learning

by GLOOM

Photoreal illustration of an older adult sleeping with overlay of memory and brain oscillation imagery, conveying sleep-based learning intervention.

Auditory targeted memory reactivation during a 2-hour nap did not improve motor retention in 20 Parkinson’s disease patients or 20 healthy older adults, even though the same cues changed sleep physiology by reducing spindle density and increasing slow-wave density.1 Research Highlights First Parkinson’s TMR test: Micca et al. studied 20 Parkinson’s disease patients and 20 …

Friedreich Ataxia MRI Study Finds 3 Progression Subtypes

by GLOOM

Photoreal illustration of brain regions affected in Friedreich ataxia with overlay of MRI imaging modalities, conveying multi-pattern subtypes.

A 2026 longitudinal MRI preprint involving 54 people with Friedreich ataxia and 57 controls found 3 biologically interpretable progression subtypes: microstructure-dominant, macrostructure-dominant, and minimal/no progression.1 The clusters make biomarker heterogeneity visible at the research level, while the classifier remains too early to assign individual patients to treatment paths. Research Highlights 3 MRI progression subtypes emerged: …